All In MedTech

Company

Olympus

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Olympus is on our public-company list (ticker 7733.T). Names searched as well: Olympus Medical Systems. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

7733.T

Listed outside the US

Public float

Unknown

Not reported in US filings

Revenue

Not reported

Net income

Not reported

R&D spending

Not reported

Cash

Not reported

Long-term debt

Not reported

Shares outstanding

Not reported

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jan 31, 2020Equity$11.5M$11.5M17Rule 506(b), 3C.1, Investment Company Act 3(c)Form D ↗Mar 13, 2020
Jul 29, 2016Equity$18.3MOpen-ended11Rule 506(b)Form D ↗Sep 16, 2016

Company details

From the company's latest Form D.

Legal name
Olympus Ascent Investors, LLC; Olympus Topco, Inc.
Headquarters
Salt Lake City, Utah
Incorporated
Delaware in 2019
Entity type
Limited Liability Company
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    3 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Olympus.

    Latest FDA decisions

    The 8 newest of 159 since 2015.

    Search the Clearance Tracker

    156 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT06592820 · 300 participants (planned) · Start Sep 3, 2025 · Primary completion Nov 28, 2028

      Device: Endoscopic Ultrasound Shear Wave Elastography (EUS) and Attenuation Imaging; FibroScan and 1 more · For: MASLD; MASH; Fibrosis, Liver and 1 more

      Sites: Newport Beach, California; Boston, Massachusetts; Danville, Pennsylvania

    • NCT04302272 · 150 participants (planned) · Start Oct 9, 2021 · Primary completion Dec 2026

      Device: Spiration Valve System (SVS) · For: Emphysema

      Sites: Phoenix, Arizona; Mountain View, California; Coral Gables, Florida · 16 sites in all

    • Modified SOLTIVE StudyNot yet recruiting

      NCT07838077 · 250 participants (planned) · Start Nov 2026 · Primary completion May 2028

      Device: SOLTIVE Premium SuperPulsed Laser System · For: Calculi, Renal; Calculi, Urinary; Benign Prostatic Hyperplasia

      Sites: Kansas City, Kansas

    28 more trials with a free account

    Reports received

    160,301

    Received Nov 1, 2025 to Nov 19, 2026. Includes 3 of another or unstated type.

    Malfunction reports

    159,360

    99% of reports

    Injury reports

    919

    0.6% of reports

    Death reports

    19

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 233,85331280
    Jan 243,95328190
    Feb 244,089296110
    Mar 244,58631020
    Apr 244,64115290
    May 244,94714920
    Jun 244,72420920
    Jul 245,10219140
    Aug 244,80919041
    Sep 244,75114440
    Oct 245,670154170
    Nov 243,08021730
    Dec 243,06417800
    Jan 253,65415830
    Feb 254,94514530
    Mar 254,80612010
    Apr 255,18711610
    May 254,51714420
    Jun 255,07913820
    Jul 256,19711140
    Aug 256,4379920
    Sep 256,9938610
    Oct 2510,53817520
    Nov 2510,1768700
    Dec 2514,76111420
    Jan 2614,2957900
    Feb 2611,3568400
    Mar 2612,6877120
    Apr 2615,4486400
    May 2614,62510610
    Jun 2613,1826520
    Jul 2613,6877830
    Aug 2613,9393423
    Sep 2614,1417130
    Oct 2611,0636640
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    7 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    600 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.